Objective: The identification of sentinel lymph nodes (SLNs) near injection sites is difficult, due to scattered gamma rays. The purpose of this study was to investigate the optimal energy windows for elimination of scattered gamma rays, to improve the detection of SLNs.
Introduction
A sentinel lymph node (SLN) is defined as the lymph node that is first to receive lymphatic drainage from a tumour. When the SLN is tumor free, the nodal basin can be regarded as free of disease, and unnecessary dissection can be avoided [1] . Arm problems, such as numbness, pain, restricted arm mobility and lymphedema are influenced by the number of lymph nodes removed. Complications from axillary lymph node dissection may be reduced by limiting the extent of dissection using SLN biopsy [2, 3] . Preoperative detection of SLNs permits surgeons to locate nodes efficiently with a gamma probe during surgery, and lymphoscintigraphy can accurately reveal the localisations of SLNs in this context [4, 5] . One of the major problems in lymphoscintigraphy is the inclusion of scattered gamma rays within the photo-peak energy window. In Compton scattering, the energy of scattered gamma rays depends on the scatter angle ( Fig. 1) [6]. Scattered gamma rays sometimes hamper the identification of SLNs near injection sites. Therefore, we hypothesised that optimal energy windows may eliminate scattered gamma rays, which could result in improved SLN detection.
The purpose of this study was to investigate the optimal energy windows for elimination of scattered gamma rays, and the method was applied to clinical studies.
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Methods
Phantom study
To evaluate the optimal energy window and the difference in collimator characteristics, the low-energy high-resolution (LEHR) collimator and the low-to medium-energy general-purpose (LMEGP) collimator, for SLN lymphoscintigraphy in breast cancer patients, we used both injection site phantoms and lymph node phantoms, to simulate injection sites and SLNs. Injection site phantoms were 2 cm in diameter and 1 cm thick, and contained 40 MBq (1.1 mCi) of Tc-99m pertechnetate. Lymph node phantoms were 5 or 10 mm in diameter and 1 cm thick, and contained 1. 
Clinical study
The study sample consisted of 56 consecutive female patients aged 56.1 ± 13.1 years, with breast cancer that was histologically diagnosed between November 6 2013 and July 2014 inclusively. One patient was excluded because written informed consent was not obtained. The tumour was on the right side in 22 patients and the left side in 32, and was bilateral in 2 patients. A 37 MBq dose of Tc-99m phytate (Fujifilm RI Pharma, Japan) was injected subcutaneously around the tumour. Location markers containing 0.3 MBq (8.1μCi) of Tc-99m pertechnetate were placed at the centre of the sternal notch and the xiphoid process. Planar imaging was performed at 10 min and 3 -4 hours after injection. The injection sites were not covered with a lead shield. The counts in the planar image were collected for 6 min in a 256 × 256 matrix, with a low-to medium-energy general-purpose (LMEGP) collimator. While the energy was centred at 140keV with a 20% window for Tc-99m, this energy window was divided into 5 sub-windows with every 4% in planar imaging. The energy window was centred at 128.8 keV ± 2%, 134.4 keV ± 2%, 140 keV ± 2%, 145.6 keV ± 2% and 151.2keV ± 2% without overlaps. A dual-head gamma camera equipped with a LMEGP collimator (Symbia T6; Siemens, Erlangen, Germany) was used for planar imaging. When the SLNs were not identified clearly, such as when the tumour was located in the upper lateral region, additional directional views were acquired. Five nuclear medicine physicians evaluated the planar images, and recorded their degrees of confidence in interpreting images with regard to the presence or absence of SLNs. The confidence levels of interpretation were evaluated using a 5-grade scale: 1, definitely not identified; 2, probably not identified; 3, equivocal; 4, probably identified; and 5, definitely identified. Detection rate was calculated as the number of patients whose average confidence levels of interpretation were more than 4, divided by the total number of patients. When the average confidence levels of interpretation were more than 4.6, the clinical interpretation was that the SLN had been definitely identified, and when it was less than 2.9 it was that it had not been identified. Average scores between 3.0 and 3.9
were deemed equivocal, and scores between 4.0 and 4.5 were deemed to indicate that the SLN was probably identified. Confidence levels of interpretation were expressed as mean ± standard deviation (SD) and median. The confidence levels were compared using the Wilcoxon signed-rank test. Regions of interest were placed on SLNs and BG, and contrast was calculated with the following equation: Contrast = (SLN activity -BG activity) / (SLN activity + BG activity). Contrast and SLN counts were compared using the Student's t-test. Statistical significance was defined as p < 0.05. The study protocol was approved by the ethical committee of Kanazawa university hospital, and written informed consent was obtained from all patients. Glass et al. [12] reported that adjustment of the energy window may improve the imaging of SLNs located close to injection sites. By acquiring only the high-energy component of the photo-peak, scattered gamma rays are reduced. Krynyckyi et al. [13] have shown that when the centre of the energy window was shifted upward by 5 keV, improved images with less background were obtained. Tsushima et al. [14, 15] reported that the contrast and detection capacity of lymphoscintigraphy were improved by using medium-energy collimator and an upper offset energy window of 146 keV ± 5%. Since lower energy windows contain a significant amount of scattered gamma rays, the image contrast was reduced when including the lower energy windows, especially near injection sites. The detectability of SLNs was more affected by image contrast than SLN counts, when the SLNs were located close to injection sites.
Results
Discussion
Although a few studies have investigated optimal energy windows for SLN imaging, none have compared conventional energy windows with optimal energy windows in a clinical setting. In our study, when an upper offset energy window, such as 145.6 keV ± 6% (after subwindows of 128.8 keV ± 2% and 134.4 keV ± 2% were eliminated from 12 background counts.
The information from lower energy windows may rule out artifact derived from injection sites. Although the photo-peak of Tc-99m occurred at approximately 141 keV, scattered gamma rays might shift the peak to the lower energy side. The energy of Compton-scattered gamma rays is reduced, depending on their scattering angle. Our 5 energy windows-based method could distinguish SLNs, and eventually reduced scattered gamma rays in planar images. When we eliminated some fractions of the lower energy windows, scattered gamma rays could be reduced while maintaining the primary gamma rays.
Some studies have discussed the optimal collimator choice for planar imaging [15] [16] [17] [18] [19] . In most cases, SLNs that were not detected were located near injection sites. Collimator imaging with lower septal penetration is effective for the accurate identification of SLNs close to injection sites; lower septal penetration, such as LMEGP collimator, reduces the appearance of star-shaped artifacts from injection sites.
The main variable parameter of the radio-pharmaceuticals used for SLN detection is particle size [4] . Phytate labelled with Tc-99m, which is mainly used for SLNs scintigraphy in Japan, forms a colloid in vivo upon reacting with ionised calcium.
Tavares et al. [20] reported that a high rate (98%) of SLNs detection was achieved with 13 a gamma probe and SLN scintigraphy using Tc-99m phytate. In addition, if SLNs are not clearly detected in the initial planar imaging, massaging of stagnate injection sites is useful to enhance regional tracer flow. Multi-direction views are also helpful to detect SLNs when the tumours are located near axillary nodes that may be concealed behind injected radioactivity [21] .
Conclusion
Because lower energy windows contain many scattered gamma rays, upper offset energy windows which exclude lower energy windows improve the image contrast of SLNs near injection sites. In our phantom and clinical studies investigating optimal energy windows, 145.6 keV ± 6% was appropriate for SLN scintigraphy near injection sites. When the 5 offset energy windows without overlaps were used, we could derive an optimal energy window appropriate for the situation after imaging. of Tc-99m pertatechnetate. 145.6 keV ± 2% (d), 151.2 keV ± 2% (e), 140 keV ± 10% (f) and 145.6 keV ± 6% (g). 
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